文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

肝功能异常与成人ECMO支持患者院内死亡相关

Liver Dysfunction Associated With In-Hospital Mortality in Adult Extracorporeal Membrane Oxygenation Support.
PubMed 文献 · Crit Care Explor · 2021-07-13
一句话结论成人ECMO支持患者中,最高总胆红素>15 mg/dL、年龄增大和最高乳酸升高与院内死亡独立相关。

该研究为单中心回顾性队列,纳入8年间接受ECMO支持的152例成人患者,主要终点为院内死亡。多因素分析显示最高总胆红素>15 mg/dL(aOR=4.40,95%CI 1.19-21.87,P=0.04)、年龄(aOR=1.03,95%CI 1.00-1.05,P=0.04)和最高乳酸(aOR=1.15,95%CI 1.06-1.26,P=0.002)与院内死亡独立相关。提示ECMO期间监测胆红素和乳酸有助于风险分层。

要点

  • 成人ECMO患者中,最高总胆红素>15 mg/dL与院内死亡独立相关(aOR=4.40,95%CI 1.19-21.87,P=0.04)。
  • 最高乳酸每升高1单位,院内死亡风险增加15%(aOR=1.15,95%CI 1.06-1.26,P=0.002),支持动态监测乳酸。
  • 年龄增大与院内死亡独立相关(aOR=1.03,95%CI 1.00-1.05,P=0.04),评估ECMO指征时应纳入年龄因素。
  • 总体院内死亡率为56%(86/152),提示该单中心成人ECMO队列死亡风险高。

适用人群与场景

  • 单中心8年间所有接受ECMO支持的成人患者(年龄19-82岁,平均50岁),包括心脏(50.0%)、呼吸(31.6%)、体外心肺复苏(13.3%)及心呼吸联合(4.6%)适应证。

诊断标准与关键阈值

  • 肝功能异常阈值:总胆红素>15 mg/dL、AST>20×正常上限、ALT>20×正常上限,满足任一即为超过阈值。

处置流程与药物剂量

  • 原文未提及具体的ECMO管理方案或药物剂量。

红旗征与不能漏的情况

  • 最高总胆红素>15 mg/dL与院内死亡独立相关(aOR=4.40,95%CI 1.19-21.87),提示需警惕肝功能恶化。
  • 最高乳酸升高与院内死亡独立相关(aOR=1.15,95%CI 1.06-1.26),提示需关注乳酸趋势。

研究设计与关键结果

  • 研究类型:单中心回顾性 review;样本量152例成人患者;单中心(芝加哥大型ECMO中心)。
  • 人群:平均年龄50岁(范围19-82岁),男性86例(56.6%),女性66例(43.4%)。
  • ECMO适应证:心脏76例(50.0%)、呼吸48例(31.6%)、体外心肺复苏21例(13.3%)、心呼吸联合7例(4.6%)。
  • ECMO支持时间:平均17天(范围1-223天),中位8天(IQR 4-17天)。
  • 主要终点:总体院内死亡率为56%(86/152)。
  • 多因素logistic分析:最高总胆红素>15 mg/dL(aOR=4.40;95%CI 1.19-21.87;P=0.04)、年龄(aOR=1.03;95%CI 1.00-1.05;P=0.04)、最高乳酸(aOR=1.15;95%CI 1.06-1.26;P=0.002)与院内死亡独立相关。

证据类型、等级与局限

  • 证据类型:单中心回顾性研究。
  • 局限:单中心、回顾性设计、样本量152例;原文未提及其他局限。

对床旁实践的改变

  • 成人ECMO支持期间应监测总胆红素和乳酸,最高总胆红素>15 mg/dL和乳酸升高提示院内死亡风险增加,可辅助风险分层。
  • 年龄增大与院内死亡相关,评估ECMO指征及预后沟通时应考虑年龄因素。
  • 该研究为单中心回顾性设计,相关阈值和关联需前瞻性验证,不能作为决策阈值直接套用。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

UNLABELLED: Extracorporeal membrane oxygenator support is a powerful clinical tool that is currently enjoying a resurgence in popularity. Wider use of extracorporeal membrane oxygenator support is limited by its significant risk profile and extreme consumption of resources. This study examines the role of markers of liver dysfunction in predicting outcomes of adult patients requiring extracorporeal membrane oxygenator support.

DESIGN: Retrospective review.

SETTING: Large extracorporeal membrane oxygenator center, Chicago, IL.

PATIENTS: This study reports a single institution experience examining all adult patients for whom extracorporeal membrane oxygenator support was used over an 8-year period. Data were collected regarding patient demographics, details of extracorporeal membrane oxygenator support provided, laboratory data, and outcomes. Trends in liver function were examined for their ability to predict survival.

INTERVENTION: Extracorporeal membrane oxygenator support, critical care.

MEASUREMENTS AND MAIN RESULTS: Mean age was 50 years (range, 19-82 yr). There were 86 male patients (56.6%) and 66 female patients (43.4%). Indications for initiation of extracorporeal membrane oxygenator support included cardiac 76 patients (50.0%), respiratory 48 patients (31.6%), extracorporeal cardiopulmonary resuscitation 21 patients (13.3%), and combined cardiac/respiratory seven patients (4.6%). Mean duration of extracorporeal membrane oxygenator support was 17 days (range 1-223 d) or median 8 days (interquartile range, 4-17 d). Overall, in-hospital mortality was 56% (86/152). Forty-five percent of adult patients (68/152) surpassed at least one of the following established liver dysfunction thresholds: total bilirubin greater than 15 mg/dL, aspartate aminotransferase greater than 20× upper limit of normal, and alanine aminotransferase greater than 20× upper limit of normal. The multivariable logistic analysis yielded three significant findings associated with in-hospital mortality: highest total bilirubin greater than 15 (adjusted odds ratio = 4.40; 95% CI, 1.19-21.87; p = 0.04), age (adjusted odds ratio = 1.03; 95% CI, 1.00-1.05; p = 0.04), and highest lactate (adjusted odds ratio = 1.15; 95% CI, 1.06-1.26; p = 0.002).

CONCLUSIONS: Increases in age, highest total bilirubin, and lactate all correlated with in-hospital mortality in multivariable analysis of patients requiring extracorporeal membrane oxygenator support.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Dobrilovic N, March R, Yin K, et al. Liver Dysfunction Associated With In-Hospital Mortality in Adult Extracorporeal Membrane Oxygenation Support. Crit Care Explor. 2021. PMID: 34278314. doi:10.1097/CCE.0000000000000484

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。